08.06.2015 • News

Solvay Opens Biotechnology Lab in Brazil

Solvay has opened its first fully dedicated Industrial Biotechnology Laboratory (IBL) in Paulinia, Brazil.
The Belgian chemical producer said the lab is designed to boost the development of innovations and solutions based on sustainable chemistry and used in a growing range of end-markets.
The fully integrated laboratory will focus chiefly on researching new processes and molecules derived from biomass, which is mostly plant or vegetable-based and abundantly available in Brazil with its favorable climate and vast surface.
Louis Neltner, general manager of Solvay's Research & Innovation group, said the new lab will allow the company to “further nourish its innovation portfolio, using renewable resources, with tailored solutions to meet sustainability demands from customers in multiple end-markets.”
"Thanks to Brazil's wide variety of biomass, competitive agricultural businesses and biotech expertise the country has all the required conditions to develop and grow products and solutions based on renewable resources."
The lab's researchers will work jointly with the group's global business units in Solvay's research and innovation centers worldwide as well as with external partners including public and private institutions. Research programs in place include projects in flavors, fragrances, surfactants, cellulose derivatives and solvents.
Solvay has been developing products and solutions based on bio-sourced raw materials such as ethanol and glycerol for several decades with an eye toward meeting the challenges posed by the scarcity of resources amid growing industrialization, urbanization and an increasing number of consumers.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.